Surmodics to Host Virtual Annual Meeting of Shareholders

Rhea-AI Summary

Surmodics, Inc. (NASDAQ: SRDX) will hold its Annual Meeting of Shareholders on February 9 at 4 p.m. CT. The meeting will be virtual, led by chair Sue Knight and CEO Gary Maharaj, who will discuss business updates and strategic initiatives. Shareholders can attend by logging on to www.virtualshareholdermeeting.com/SRDX23 at least five minutes before the meeting. A replay will be available until February 9, 2024. Surmodics specializes in medical device technologies and aims to enhance disease detection and treatment.

Virtual Meeting on February 9 at 4 p.m. (CT)

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Thursday, February 9, at 4 p.m. CT (5 p.m. ET), as a virtual meeting.

Sue Knight, chair of the board, will lead the meeting, and Gary Maharaj, chief executive officer, and will provide a brief update on business and key strategic initiatives underway at the Company.

To attend the virtual meeting, go to www.virtualshareholdermeeting.com/SRDX23 at least five minutes prior to the start of the meeting to log in. A webcast replay of the Annual Meeting will be available until February 9, 2024.

About Surmodics, Inc.

Surmodics is a leading provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. Surmodics also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements. This key growth strategy leverages the combination of the Company’s expertise in proprietary surface modification and drug-delivery coating technologies, along with its device design, development and manufacturing capabilities. The Company’s mission is to improve the detection and treatment of disease. Surmodics is headquartered in Eden Prairie, Minnesota. For more information, visit www.surmodics.com. The content of Surmodics’ website is not part of this press release or part of any filings that the company makes with the SEC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005389/en/

Surmodics Investor Inquiries:

Jack Powell, Investor Relations

ir@surmodics.com

Source: Surmodics, Inc.

FAQ

When is Surmodics' Annual Meeting of Shareholders scheduled?

Surmodics' Annual Meeting of Shareholders is scheduled for February 9 at 4 p.m. CT.

Who will lead the Annual Meeting of Surmodics on February 9?

The meeting will be led by chair Sue Knight and CEO Gary Maharaj.

How can I attend the Surmodics Annual Meeting virtually?

To attend the meeting, visit www.virtualshareholdermeeting.com/SRDX23 at least five minutes prior to the start.

What will be discussed during the Surmodics Annual Meeting?

The meeting will include business updates and key strategic initiatives presented by CEO Gary Maharaj.

Is there a replay available for the Surmodics Annual Meeting?

Yes, a replay of the Annual Meeting will be available until February 9, 2024.